Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-10 6:51 pm Purchase | 2025-01-06 | 13G | BioLineRx Ltd. BLRX | Mitchell P. Kopin | 2,555,903 4.990% | 2,077,581 (+434.35%) | Filing History |
| 2023-10-26 2:18 pm Purchase | 2023-10-09 | 13D | BioLineRx Ltd. BLRX | Hong Seng Technology Ltd | 2,560,926 9.500% | 2,560,926 (New Position) | Filing History |
| 2022-02-11 06:49 am Purchase | 2021-12-31 | 13G | Akanda Corp. AKAN | Mitchell P. Kopin | 9,285 1.000% | 9,285 (New Position) | Filing History |
| 2021-02-16 4:10 pm Purchase | 2020-12-31 | 13G | BioLineRx Ltd. BLRX | Novartis Pharma AG | 125,000 1.000% | 116,667 (+1400.00%) | Filing History |
| 2021-02-12 9:40 pm Sale | 2020-12-31 | 13G | BioLineRx Ltd. BLRX | Altium Capital Management LLC | 450,262 3.700% | -187,500 (-29.40%) | Filing History |
| 2021-02-12 4:05 pm Purchase | 2020-12-31 | 13G | BioLineRx Ltd. BLRX | SENVEST MANAGEMENT, LLC | 68,125 0.770% | 68,125 (New Position) | Filing History |
| 2021-01-29 06:19 am Purchase | 2020-12-31 | 13G | BioLineRx Ltd. BLRX | Mitchell P. Kopin | 478,322 5.200% | 478,322 (New Position) | Filing History |
| 2021-01-06 12:19 pm Purchase | 2020-12-31 | 13G | BioLineRx Ltd. BLRX | SABBY MANAGEMENT LLC | 29,039 11.000% | 468 (+1.64%) | Filing History |
| 2020-11-03 4:39 pm Sale | 2020-10-30 | 13G | BioLineRx Ltd. BLRX | BIOTECHNOLOGY VALUE FUND L P | 148,671 1.900% | -632,391 (-80.97%) | Filing History |
| 2020-06-05 4:16 pm Purchase | 2020-05-26 | 13G | BioLineRx Ltd. BLRX | Armistice Capital, LLC | 25,952 4.990% | 25,952 (New Position) | Filing History |
| 2020-06-04 9:13 pm Purchase | 2020-05-26 | 13G | BioLineRx Ltd. BLRX | Altium Capital Management LLC | 637,762 8.600% | 637,762 (New Position) | Filing History |
| 2020-06-04 7:06 pm Purchase | 2020-05-26 | 13G | BioLineRx Ltd. BLRX | Mitchell P. Kopin | 478,322 6.100% | 478,322 (New Position) | Filing History |
| 2020-06-01 5:37 pm Sale | 2020-05-28 | 13G | BioLineRx Ltd. BLRX | BIOTECHNOLOGY VALUE FUND L P | 781,062 11.800% | -17,498 (-2.19%) | Filing History |
| 2020-05-26 2:54 pm Purchase | 2020-05-26 | 13G | BioLineRx Ltd. BLRX | SABBY MANAGEMENT LLC | 28,571 11.000% | 28,571 (New Position) | Filing History |